All News about Livanova Plc OR Sh
![](https://mms.businesswire.com/media/20230920458015/en/555341/22/LN-Logo-Main-PANTONE.jpg)
LivaNova Announces Marco Dolci, President of Cardiopulmonary, to Retire at the End of 2023
September 21, 2023
From LivaNova PLC
Via Business Wire
![](https://mms.businesswire.com/media/20230920416320/en/555341/22/LN-Logo-Main-PANTONE.jpg)
LivaNova to Announce Third-Quarter 2023 Results
September 20, 2023
From LivaNova PLC
Via Business Wire
![](https://mms.businesswire.com/media/20230830793488/en/1878567/5/LivaNova_Essenz_ILBM_image.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2.jpeg?width=1200&height=800&fit=crop)
The Latest Analyst Ratings for LivaNova
July 27, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
LivaNova Earnings Preview
July 25, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Looking Into LivaNova's Return On Capital Employed
May 09, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2023
September 06, 2023
Via Benzinga
![](https://mms.businesswire.com/media/20230824832887/en/555341/22/LN-Logo-Main-PANTONE.jpg)
LivaNova to Present at the Baird Global Healthcare Conference
August 24, 2023
From LivaNova PLC
Via Business Wire
![](/next-assets/images/schema-image-default.png)
Recap: LivaNova Q1 Earnings
May 03, 2023
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/07/healthcare-1600.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/07/26/alphabet_-_logo_0.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230726612343/en/555341/22/LN-Logo-Main-PANTONE.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://mms.businesswire.com/media/20230614005001/en/555341/22/LN-Logo-Main-PANTONE.jpg)
![](https://mms.businesswire.com/media/20230613082417/en/555341/22/LN-Logo-Main-PANTONE.jpg)
![](https://mms.businesswire.com/media/20230503005123/en/555341/22/LN-Logo-Main-PANTONE.jpg)
![](https://mms.businesswire.com/media/20230414005434/en/555341/22/LN-Logo-Main-PANTONE.jpg)
LivaNova Board of Directors Announce Leadership Changes
April 14, 2023
From LivaNova PLC
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2023/04/17/satsuma_pharmaceuticals_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_6641.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://mms.businesswire.com/media/20230322005006/en/555341/22/LN-Logo-Main-PANTONE.jpg)
![](https://mms.businesswire.com/media/20230309005787/en/1735168/22/Essenz_DMcDonald_Milano_2023_03_02-12.jpg)
![](https://mms.businesswire.com/media/20230309005243/en/555341/22/LN-Logo-Main-PANTONE.jpg)
From LivaNova PLC
Via Business Wire
![](https://mms.businesswire.com/media/20230222005201/en/555341/22/LN-Logo-Main-PANTONE.jpg)
LivaNova Reports Fourth-Quarter and Full-Year 2022 Results
February 22, 2023
From LivaNova PLC
Via Business Wire
![](https://mms.businesswire.com/media/20230208005127/en/1707624/22/LIVN_Essenz_OR_team_2_CAPTION-One_of_the_first_clinical_cases_with_Essenz_at_San_Donato_Hospital%2C_Italy.jpg)
![](https://mms.businesswire.com/media/20230131005958/en/1704927/22/SenTiva_Duo-05_Modified.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image_118.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230118005021/en/555341/22/LN-Logo-Main-PANTONE.jpg)
LivaNova to Announce Fourth-Quarter and Full-Year 2022 Results
January 18, 2023
From LivaNova PLC
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_9525.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For December 21, 2022
December 21, 2022
Via Benzinga
![](https://mms.businesswire.com/media/20221213005928/en/555341/22/LN-Logo-Main-PANTONE.jpg)
![](https://mms.businesswire.com/media/20221130005320/en/555341/4/LN-Logo-Main-PANTONE.jpg)
LivaNova to Present Scientific Data at American Epilepsy Society 2022 Annual Meeting
November 30, 2022
From LivaNova PLC
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.